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Expansion of a polyglutamine sequence in the N terminus of
huntingtin is the gain-of-function event that causes Hunting-
ton’s disease. This mutation affects primarily the medium-size
spiny neurons of the striatum. Huntingtin is expressed in many
neuronal and non-neuronal cell types, implying a more general
function for the wild-type protein. Here we report that wild-type
huntingtin acts by protecting CNS cells from a variety of apo-
ptotic stimuli, including serum withdrawal, death receptors, and
pro-apoptotic Bcl-2 homologs. This protection may take place
at the level of caspase-9 activation. The full-length protein also
modulates the toxicity of the poly-Q expansion. Cells express-
ing full-length mutant protein are susceptible to fewer death
stimuli than cells expressing truncated mutant huntingtin.
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Huntington’s disease (HD) is an autosomal neurodegenerative
disorder caused by a (CAG)n expansion in the gene IT15 (Hun-
tington’s disease Collaborative Research Group, 1993). This
trinucleotide expansion encodes for a polyglutamine (QN) stretch
in the encoded protein, huntingtin (Htt), resulting in progressive
neuronal death with clinical symptoms of chorea and dementia
(Ross et al., 1997). Studies on the cellular localization of the
mRNA and protein have revealed that wild-type (wt) and mu-
tated (mu) Htt are expressed throughout the nervous system as
well as in non-neuronal cells (Sharp and Ross, 1996). Despite this
widespread distribution, only specific neurons in the striatum and
cortex are affected in HD (Vonsattel et al., 1985; Kowall et al.,
1987). The cytotoxicity of the mu protein is believed to be caused
by a gain-of-function effect induced by the presence of the ex-
panded CAG (for review, see MacDonald and Gusella, 1996).
The molecular mechanism by which the poly-Q expansion
triggers cell death is not understood (Reddy et al., 1999). Intra-
cellular inclusions may be involved, but it is not clear whether they
have a direct role in pathogenesis or are involved in progression
(Davies et al., 1997; Di Figlia et al., 1997; Saudou et al., 1998) (for
review, see Kim and Tanzi, 1998; Sisodia, 1998; Gutekunst et al.,
1999; Hodgson et al., 1999). Proteolytic cleavage has been impli-
cated by the findings of N-terminal fragments in inclusions and
the fact that Htt is a caspase substrate and is actively cleaved
during apoptosis in cultured cells (Goldberg et al., 1996; Davies
et al., 1997; DiFiglia et al., 1997; Wellington et al., 1998; Kim et
al., 1999). Experiments performed in primary striatal neurons
showed that the poly-Q cytotoxicity can be inhibited by the
anti-apoptotic protein Bcl-Xl and caspase inhibitors (Saudou et
al., 1998). Involvement of caspases is also indicated by the obser-
vation that dominant negative caspase-1 delays disease progres-
sion in transgenic mice (Ona et al., 1999). Studies using an
isolated poly-Q sequence have suggested that the first pathogenic
event is the aggregation and activation of caspase-8 (Sanchez et
al., 1999). Finally, activation of caspase-3 and caspase-9 was
reported in HD lymphoblasts (Sawa et al., 1999).
Much less is known about the physiological roles of wtHtt.
Mice with a targeted disruption of the Htt gene die at embryonic
day 7.5 (Duyao et al., 1995; Nasir et al., 1995; Zeitlin et al., 1995).
Moreover, analysis of mice expressing ,50% of wtHtt showed
extensive brain abnormalities and died shortly after birth (White
et al., 1997). These data suggest that Htt is an important factor
during embryonic development and that its role is not restricted
to the nervous system.
To assess the function of wt and muHtt in neural cells, we
developed a cell culture system composed of clonal striatal-
derived cells overexpressing the wt or muHtt protein. We found
that wtHtt has a role as a pro-survival molecule and acts upstream
of caspase-3 and downstream of pro-apoptotic Bcl-2 proteins. We
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also found that toxicity of the poly-Q expansion is modulated by
the length of Htt backbone.
MATERIALS AND METHODS
Constructs and transfections. FLwt [FL-23Q] and FLmu [FL-82Q] (Coo-
per, 1998), N548wt [nt1955–15] and N548mu [nt1955–128] (Hackam, 1998),
myc-tagged N63wt [N63–18Q] and N63mu [N63–82Q] (Cooper, 1998)
were subcloned into pLXSP vector or cotransfected with pLXSP as
previously described (Cattaneo et al., 1996a). Briefly, ST14A cells were
grown routinely at 33°C in the presence of DMEM supplemented with
10% fetal bovine serum as described (Cattaneo and Conti, 1998). Ten
micrograms of cDNA were transfected using calcium phosphate or lipo-
fectamine (Life Technologies) (Cattaneo et al., 1996b). Resistant clones
were selected with puromycin 3 mg/ml, expanded, and cryopreserved.
Transfection with the empty plasmid was also performed. For each
construct, ;20 colonies were isolated with cloning rings and analyzed.
Protein expression assay. Expression of the cDNAs was analyzed by
Western Blot (WB) using antibody MAB2166 (dilution 1:2000; Chemi-
con, Temecula, CA), BKP1 (dilution 1:50), Ab1 (1 mg/ml, kindly pro-
vided by M. DiFiglia), and Ap194 (dilution 1:1000; kindly provided by A.
Sharp). For N63wt and N63mu cDNAs immunoprecipitation with an
anti-myc antibody (9E10, dilution 1:100; Calbiochem, La Jolla, CA) was
performed after metabolic labeling of the cells. A total of 50 mg of
proteins was loaded in each lane. To control for loading of the gels, an
anti-actin antibody (Sigma, St. Louis, MO; 1:2000) was used. All assays
were performed on cells that have been cultured up to the 25th passage.
Cell counting, MTT assay, and BrDU measurement. Cells were plated in
triplicates into six well plates at a density of 2 3 10 5/well. After 8 hr
incubation at 33°C the cultures were washed with HBSS, the medium was
replaced with serum-deprived medium (SDM; composition: F-12/
DMEM, 5 mg/ l insulin, 100 mg/ l transferrin, 20 nM progesterone, 30 nM
selenite, 60 mM putrescine, 2 mM glutamine, 0.11 gm/l sodium pyruvate,
3.7 gm/l sodium bicarbonate, and 3.9 gm/l HEPES) and then incubated
at 39°C. At the times indicated, cells were trypsinized, resuspended in 20
ml Isoton, and counted using a Coulter Counter machine (ZM; Coulter
Instruments). For MTT assays, cells were exposed to 3-[4.5-dimethylthiazol-
2-phenyl]-2.5-diphenyl-tetrazolium bromide, and release of formazan
from mitochondria was quantified at 560 nm using an ELISA plate
reader. 3-Nitro-propionic acid was obtained from Sigma.
For quantitation of the mitotic events, a 6 hr pulse of bromodeoxyuri-
dine (BrDU; 10 mM, Sigma) was given to the cells (Cattaneo et al., 1994).
At the end of incubation, cells were rinsed, fixed for 15 min in 4%
paraformaldehyde, permeabilized with 0.5% Triton X-100 for 5 min, and
then incubated with anti-BrDU antibody (Becton Dickinson, Mountain
View, CA; 1:50) (Magrassi et al., 1998).
Secondary FITC conjugated antibody to (Sigma) was used at 1:200.
The cells were viewed with a Zeiss (Axiovert) microscope, and positive
cells were scored manually.
DNA fragmentation and caspase activity. Cells were harvested in 10 mM
Tris, pH 8, 20 mM EDTA, and 2% Triton X-100. Low molecular weight
DNA was extracted by phenol /chloroform extractions and DNA precip-
itated with isopropanol. DNA fragmentation was detected on a 1%
agarose gel.
Measurement of caspase-3 activity: samples of 1–2 3 10 6 cells were
rinsed in cold PBS and lysed in a buffer containing 25 mM HEPES, pH
7.5, 5 mM EDTA, 1 mM EGTA, 5 mM MgCl2, 5 mM dithiothreitol, 1%
3-[-(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid
(CHAPS), 10 mg/ml pepstatin and leupeptin, and 1 mM PMSF. The cell
lysates were centrifuged (for 3 min at 5000 rpm), and the supernatants
stored at 280°C. Lysates were incubated at 37°C in a buffer containing 25
mM HEPES, pH 7.5, 10% sucrose, 0.1% CHAPS, and 1 mM DTT
supplemented with Ac-DEVD-7-amino-4-methylcoumarin (amc) (50
mM). The increase of fluorescence after the cleavage of the fluorogenic
amc moiety was monitored and then quantified in a LS50 Perkin-Elmer
(Emeryville, CA) fluorimeter (excitation, 380 nm; emission, 460 nm).
Protein content was assayed by the bicinchoninic acid procedure. For
quantitation, standard curves using increasing concentrations of amc
moiety were performed in parallel.
Constitutively active caspase-3 (Srinivasula et al., 1998) or pLXSP
plasmid (as a control) were cotransfected with the EGFP-N1 plasmid
(Clontech, Palo Alto, CA) in the ratio 10:1. Cell viability was determined
30 hr after transfection by counting the ratio of green-stained cells
(EGFP-positive) versus total number of cells.
TUNEL assay. 2–3 3 10 5 cells were transfected with 250 ng of
pCMV-EGFP and 1 mg of the indicated plasmids (0.4 mg for Bik and
Bak). Expression from the transiently transfected genes was confirmed by
WB and found to range between 10 and 15 times above control. After 24
hr the cells and their supernatant were harvested, and terminal trans-
ferase terminal deoxynucleotidyl transferase-mediated biotinylated UTP
nick end labeling (TUNEL) was essentially performed as described
previously, using phycoerythrin (PE)-conjugated avidin (Gorczyca et al.,
1993). Stained cells were analyzed by dual color FACS, collecting at least
10,000 events. The number of TUNEL-positive cells was estimated by
gating on the EGFP-expressing cells, excluding $95% of untransfected
cells. Transfection efficiencies were ;30–40%. The PE gate was set using
vector-only transfected cells, excluding $95% of unstained cells. Back-
ground death was introduced by the transfection procedure and varied
between individual experiments, but was constant within any given
experiment. Therefore, background death was estimated by transfection
of control protein 14-3-3 and subsequently subtracted from the data.
Statistical analysis. Data reported in Figures 3, 4, and 6 and in Results
were compared using the one-way ANOVA test (a p value , 0.05 was
considered significant). Statistical analysis for data reported in Figure 7
is nonparametric, and SD derives from data obtained in three different
experiments.
RESULTS
Expression of wt and muHtt in ST14A striatal cells
Conditionally immortalized ST14A cells were stably transfected
with full-length wt or poly-Q expanded Htt constructs (FLwt and
FLmu, respectively) or with the Htt truncations (N548wt, N548mu,
N63wt, and N63mu), as outlined in Figure 1A.
Expression of the exogenous proteins in the different subclones
was confirmed by Western blot analysis (Fig. 1B) and immuno-
cytochemistry (data not shown) using antibody MAB2166 raised
against aa 181–810 of the Htt protein. As shown, a band of 340
kDa is visible on a 6% SDS-PAGE in the FLwt and FLmu clones.
Similarly, a 72 kDa band is present in N548wt clones, whereas
N548mu shows a 115 kDa band. This decreased electrophoretic
mobility is attributable to the expanded CAG. Identical results
were obtained with Ab1, BKP1, and AP194 antibodies (data not
shown). Because the N63 constructs are myc-tagged, their expres-
sion was confirmed by an anti-myc antibody (Fig. 1B).
Size and stability of the exogenously expressed proteins over
time was confirmed on lysates obtained from cells at the 4th, 12 th
and 25th passages. A representative Western blot performed on
lysates from N548wt and N548mu cells is shown in Figure 1C. As
visible, the intensity of the immunoreactive band in cells bearing
the wild-type or mutated protein did not decline with time in
vitro, up to the 25th passage. In addition, the size of the immu-
noreactive band remained the same, indicating that the poly-Q
repeat is stably replicated in ST14A cells.
Wt and muHtt differentially affect cell viability
ST14A cells were derived from the embryonic striatum via ret-
roviral transduction of the temperature-sensitive version of the
Large-T Antigen (Cattaneo et al., 1994; Cattaneo and Conti,
1998). ST14A cells grow in 10% serum at the permissive temper-
ature of 33°C (Fig. 2a) with a doubling time of 36 hr (Cattaneo et
al., 1996a). Shifting to the nonpermissive temperature of 39°C
leads to degradation of the Large-T Antigen, with consequent
block of cell proliferation and reversal of the phenotype back to
that of a differentiating neuroblast. This was better demonstrated
in in vivo transplantation studies (Cattaneo et al., 1994; Lundberg
et al., 1997; Benedetti et al., 2000). When ST14A cells were
exposed in vitro to 39°C in serum-deprived medium (SDM), cells
changed morphology but also their viability decreased with time
in a highly reproducible manner (Fig. 2b). In these conditions,
increased cell death was observed in cells expressing the N548mu
construct (Fig. 2d). In sharp contrast, cells overexpressing the
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N548wt cDNA remained viable in the same culturing conditions
(Fig. 2f).
Quantitations of these effects by Coulter Counter (Fig. 3a,b)
and MTT (which measures cell viability and/or mitochondrial
activity; Fig. 3c,d) assays confirmed that all clones behaved ap-
proximately the same in normal growth conditions (Fig. 3a,c).
However, when challenged by serum deprivation at 39°C, signif-
icant differences in cell viability and mitochondrial activity were
measured (Fig. 3b,d). ST14A cells (open squares) show, in both
assays, the typical decrease in cell viability. This effect was more
rapid in N548mu cells (open circles). Remarkably however, when
N548wt was overexpressed (open diamonds), cell viability was
maintained even at 72 hr, and decreased only at longer time
points (96 hr). Analysis of protein levels at these later time points
at 39°C revealed that the decrease in cell viability correlated with
a reduction in the level of the exogenous protein (data not
shown), further confirming the relationship between expression
of wtHtt and the phenotype observed. This correlation was fur-
ther substantiated by the finding that subclones that did not
express the exogenous proteins behaved as parental ST14A cells.
To exclude the possibility that increased cell number in the
presence of N548wt was caused by cell proliferation, a 6 hr BrDU
pulse was given to cells exposed to 39°C for 48 or 72 hr. We found
that parental, wt, and muHtt-expressing cells divided with the
same rate at 33°C but, no division was detected at 39°C in all
clones, including N548wt cells (data not shown). As expected, all
clones were also negative for the Large-T Antigen at 39°C (data
not shown). These data indicate that N548wt acts by increasing
cell survival and not cell division.
The pro-survival effect of wtHtt was observed in cells bearing
the N548wt construct. Analogously, expression of FLwt under the
same conditions produced a similar protective effect (Fig. 3d,
asterisk). In contrast, cells expressing a shorter N63 cDNA in the
wt form (Fig. 3d, filled diamond) were not protected and showed
the same profile as parental cells. These data indicate that the
protective effect of wtHtt requires a segment of the protein
between aa63 and aa548.
Finally, exposure of the cells to another stress stimulus,
3-nitropropionic acid (3-NP), an inhibitor of complex I activity,
revealed a similar protective effect in N548wt and FLwt cells
compared to parental ST14A cells. Figure 4 shows that cultures of
parental ST14A cells exhibited a dose-dependent decrease in cell
Figure 1. Expression of wt and muHtt in stable cell clones. A, Outline of
the Htt constructs used and abbreviation of the stable ST14A subclones
obtained. B, Expression of wt and muHtt in stable cell clones. Western
blot analysis on lysates from clones expressing FLwt (9–25 clone), FLmu
(10–6 clone), N548wt (7–12 clone), N548mu (8–2 clone), N63wt (13–5
clone), and N63mu (14–2 clone). The FL and 548aa-truncation were
detected with MAB2166 after electrophoresis on a 6 or 10% SDS-PAGE,
respectively. The shorter 63aa protein was revealed by an anti-myc anti-
body after running the samples on a 15% SDS-PAGE. Each blot includes
a lane with lysates from parental ST14A cells. Native huntingtin in the
cells is detectable at longer exposures. C, Lysates from 7–12 and 8–2
clones were analyzed for protein expression after 5, 10, and 25 passages in
vitro. Equal loading was confirmed by reacting the membrane with an
anti-actin antibody.
Figure 2. Morphology and confluency of parental ST14A (a, b), N548mu
(8–2 clone) (c, d), and N548wt (7–12 clone) (e, f ) cells in regular
passaging conditions (i.e., at 33°C in serum; a, c, e) and after exposure to
serum-deprived medium at 39°C for 48 hr (b, d, f ). N548wt evokes
increased cell survival, whereas N548mu leads to higher cell death in the
cultures with respect to parental ST14A cells.
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viability and/or mitochondrial activity by MTT assay after 1 and
5 mM 3-NP. This decrease was more evident in N548mu cells.
However, cells from a representative clone expressing N548wt
were almost completely protected by the action of the toxin. The
same was observed in other two N548wt clones (data not shown)
and in cells bearing the FLwt protein (Fig. 4). We concluded that
wtHtt can protect from mitochondrial toxins.
MuHtt induces, whereas wtHtt prevents, apoptotic
cell death
To determine if the cell death observed in the presence of
N548mu is attributable to apoptosis and if N548wt (and FLwt)
prevented DNA fragmentation, we performed the temperature
shift experiment, followed by DNA analysis or Hoechst staining.
As visible in Figure 5A, ST14A cells showed DNA laddering at 20
hr after the shift. Consistent with the above data, the appearance
of the laddering occurred in N548mu at 1 and 4 hr after the shift.
Remarkably however, cells expressing the N548wt showed no
DNA laddering even at 20 hr after the shift. Similarly, Figure 5B
shows that cultures of cells expressing N548mu (d) present an
higher percentage of nuclei with condensed DNA with respect to
parental ST14A cells. This phenomenon was not observed in
N548wt cells ( f). These results together indicate that wtHtt
directly influences cell survival and acts as an anti-apoptotic
protein in neural cells.
The data reported so far also indicate that N548mu exacerbates
apoptotic cell death in ST14A cells. As discussed later, however,
Flmu cells behave differently from N548mu cells.
WtHtt prevents caspase-3 activation by acting at the
level of caspase-9
In search of the molecular target of wtHtt action, we first ana-
lyzed whether wtHtt affected the activity of the caspase cascade.
We therefore examined the effect of the temperature shift on the
activity of the effector caspase-3. Figure 6A shows caspase-3-like
activity measured by monitoring the release of the fluorogenic
amc moiety from the caspase-3-specific substrate Ac-DEVD-amc.
As shown, parental ST14A cells have a low basal level of caspase-
3-like activity in normal growth conditions. Exposure of the cells
to SDM at 39°C led to an increase in activity, in good agreement
with the tendency of ST14A cells to undergo apoptotic cell death
in these conditions. Under the same conditions, a twofold to
fivefold greater activity was measured in N548mu cells. Most
significant, the N548wt-expressing cells had a lower level of
caspase-3-like activity than in the parental line throughout the
duration of the experiment (Fig. 6A), in agreement with the
observations presented above. Similar results were obtained with
two other clones expressing N548wt or with the clones expressing
FLwt Htt. These data indicate that wtHtt acts by inhibiting
caspase-3-like activation. To further demonstrate this point, pa-
rental ST14A and cells bearing N548wt or FLwt Htt were tran-
siently cotransfected with a constitutively active caspase-3 con-
struct and the EGFP plasmid. As shown in Figure 6B,
transfection of active caspase-3 kills all cells efficiently indepen-
dent of upstream signaling and, according to our data, after the
site where wtHtt exerts its protective effect.
Figure 3. Coulter counter (a, b) and MTT (c, d) assays on parental
ST14A (open square), N548mu (open circle), and N548wt (open diamond)
cells. a and c refer to the normal passaging conditions, i.e., 33°C in serum.
b and d indicate the values obtained after exposure at 39°C in SDM. The
graphs show the mean and SE of MTT assays (n 5 12 independent
experiments) and Coulter counter assays (n 5 4 independent experi-
ments) performed on three clones expressing N548wt and on two clones
bearing the N548mu cDNA. Two clones expressing N63wt ( filled dia-
mond) and two expressing FLwt (asterisk) were analyzed by the same
assay. All these clones behaved as parental ST14A cells in normal pas-
saging conditions.
Figure 4. A, Modification in cell viability and/or mitochondrial activity
after 3-NP exposure. Cells were exposed to the indicated doses of 3-NP
and analyzed after 48 hr by MTT assay. Parental ST14A cells and
representative clones expressing N548wt or N548mu are shown. Protec-
tion from 3-NP is also seen in FLwt cells (*p , 0.05 with respect to
parental cells). Shown is one of three independent experiments per-
formed on the different clones that gave the same results. B, Hoechst
33258 staining of the supernatant from ST14A cells shows that 3-NP
exposure induces apoptotic cell death.
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These data confirm that wtHtt acts upstream of caspase-3
activation.
In an attempt to deliver more defined death stimuli and better
identify the site of action of wtHtt, we next transfected the cells
with various pro-apoptotic genes (Fig. 7). We found that cells
expressing wtHtt were completely protected from death induced
by p55/TNFRI death receptor as well as by the pro-apoptotic
Bcl-2 family members, BIK and BAK. Even after transfection of
the apical caspase-9, the number of TUNEL-positive cells was
reduced in wtHtt-expressing cells.
These data indicate that wtHtt acts upstream of caspase-3 and
possibly at the level of caspase-9 activation.
The caspase-3 zymogen and BclXL–Bcl2-associated
death promoter synergize with the mutation
Interestingly, whereas transfection of most death inducers had
similar effects in parental ST14A, N548mu, or Flmu cells, trans-
fection of the zymogen (inactive) form of caspase-3 killed the
mutant expressing cells efficiently (Fig. 7). The same construct
was inefficient in parental or wtHtt-expressing cells (Fig. 7),
reflecting the tight control normally exerted on caspase-3 cleavage
in these and other cells (Srinivasula et al., 1998). We concluded
that expression of the poly-Q expanded protein conferred
caspase-3 processing ability selectively in N548mu and Flmu
cells. Finally, Figure 7 also shows that expression of BclXL–Bcl2-
associated death promoter (BAD) produced an increase in
TUNEL-positive cells only in clones expressing muHtt con-
structs. This indicates that muHtt toxicity feeds into a pathway
that requires BAD or a BAD-like function and argues against a
direct activation of caspase-3.
Flmu cells are killed by fewer stimuli compared to
N548mu cells
Of note and surprisingly, whereas FLmu and N548mu cells were
both as efficiently killed by caspase-3 or BAD transfection, FLmu
cells were found to be resistant to other stress stimuli. For
example, in contrast to N548mu cells (Fig. 3), exposure of FLmu
cells for various periods of time to SDM at 39°C did not evoke
increased cell demise compared to parental cells (absorbance
ratio at various time points after exposure to SDM at 39°C with
Figure 5. A, DNA laddering analysis in ST14A cells, in N548mu cells (8–2
clone), and N548wt cells (7–12 clone) after the temperature and serum-
deprived medium shift. Low molecular weight DNA samples were prepared 1,
4, and 20 hr after the shift. As a control, samples from cells in normal growth
conditions (33°C) were included (0 time). These data were replicated in
another independent experiment. B, Hoechst 33258 staining of parental
ST14A (a, b), N548mu (c, d), and N548wt (e, f ) cells at 33°C (a, c, e) and 39°C
(b, d, f ). A higher number of cells with condensed DNA is visible in N548mu
cells (d) with respect to controls (parental ST14A, b). No DNA condensation
is observed in N548wt cells ( f ).
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respect to T0 hr, parental ST14A cells: T2 hr100 6 7.4; T32 hr82.3 6
3.3; T48 hr 5 48.0 6 1.8; Flmu cells, 10–6 clone: T2 hr 5 100 6 7.3;
T32 hr 5 100.3 6 11.7; T48 hr 5 58.1 6 6.1; Flmu cells, 10–11
clone: T2 hr 5 100 6 11.2; T32 hr 5 84.9 6 1.9; T48 hr 5 57.7 6 0.8).
Similarly, 3-NP exposure produced a decrease in cell viability
and/or mitochondrial activity in N548mu cells (Fig. 4) but was
inefficient in Flmu cells (absorbance ratio in the presence of 3-NP
compared to untreated cultures, parental ST14A cells: 1 mM 5
77.1 6 7.3; 5 mM 5 63.1 6 4.2; Flmu cells, 10–6 clone: 1 mM 5
83.5 6 6.6; 5 mM 5 65.8 6 4.9; Flmu cells, 10–11 clone: 1 mM 5
72.4 6 7.0; 5 mM 5 51.9 6 2.7). These data suggest that expres-
sion of a CAG as part of the FL protein modifies its toxicity.
Accordingly, cells expressing the full-length protein are suscep-
tible to fewer death stimuli compared to cells expressing trun-
cated versions of the mutated protein.
DISCUSSION
HD is caused by an expanded poly(Q) in Htt, a protein of 340
kDa molecular weight with cytoplasmic location, and no func-
tional domains that was found to be crucial during embryonic
development. Htt is widely distributed in the CNS, however it is
unlikely that Htt plays a specific role in neuronal differentiation
because Htt2/2 embryonic stem cells turn into mature neurons
in vitro in the same way as the wild-type counterparts (Metzler et
al., 1999).
To address the question of the exact physiological role of wtHtt
in CNS cells and whether and how it relates to muHtt action, we
have obtained striatal derived cells stably expressing a wt or mu
poly(Q) stretch in the context of the full-length Htt protein or in
the N-terminal 548aa or 63aa truncations. We show that, in this
cellular system, wtHtt acts as a pro-survival molecule. This effect
is observed only when full-length protein or the N548 Htt trun-
cation is expressed. Further deletion of the protein to an
N-terminal 63aa fragment resulted in the loss of the pro-survival
effect. These data indicate that the protective effect of wtHtt
requires at least a segment of the protein between aa63 and aa548.
Previous work demonstrated that homozygous mice with a
targeted disruption in the Htt gene do not survive to term and
suffer early postimplantation embryonic lethality (Duyao et al.,
1995; Nasir et al., 1995; Zeitlin et al., 1995; White et al., 1997).
More recent morphometric and ultrastructural analysis per-
formed on heterozygous mice, which survive to adulthood, iden-
tified neuronal loss with signs of apoptosis in the basal ganglia of
adult animals (O’Kusky et al., 1999). In our system, we found that
wtHtt specifically interferes with the cell death machinery. Serum
withdrawal and exposure to mitochondrial toxins led to apoptotic
death in parental cells. Mu Htt-expressing cells were sensitized to
these apoptotic stimuli. In contrast, these stimuli were ineffective
in cells expressing wtHtt. The data indicate that wtHtt directly
influences cell survival by acting as an anti-apoptotic protein. Htt
is also an important survival factor earlier in development be-
cause its absence evokes increased apoptosis in the epiblast, a
structure of the embryo known to give rise to the future ectoderm
(Duyao et al., 1995).
To delineate the mechanism of wtHtt anti-apoptotic function,
we transiently expressed several pro-apoptotic genes in the dif-
ferent ST14A subclones. We found that cells expressing wtHtt
were protected from cell death induced by death receptors, by the
pro-apoptotic Bcl-2 family members (Bik and Bak), as well as by
caspase-9. This protection from multiple apoptotic inducers im-
plies that wtHtt acts on components of the common death effector
pathway. Furthermore, the protection from pro-apoptotic Bcl-2
homologs implies that wtHtt is acting on mitochondrial or post-
mitochondrial apoptotic events. Once caspase-9 is activated by
the apaptosome complex consisting of Apaf-1 and cytochrome C
(Cecconi et al., 1998; Yoshida et al., 1998), it directly activates the
Figure 6. A, Measurement of caspase-3-like activity. The release of the
fluorogenic amc moiety from the caspase-3-specific substrate Ac-DEVD-
amc is reported at various times (0, 3, 6, 9, and 12 hr) after the temper-
ature shift. Basal levels of caspase-3 (time 0, white bar) were obtained at
33°C. Data are expressed as nanomoles of cleaved substrate. Shown is one
of three experiments performed on different clones that gave similar
results. B, Cotransfection of a constitutively active caspase-3 together with
the EGFP plasmid in parental ST14A (open bars), N548wtHtt (black bars),
and FLwtHtt ( gray bars) cells. Cells were transiently cotransfected with
the active caspase-3 or a control vector (pLXSP) together with the
EGFP-N1 plasmid (Clontech). Cell viability was determined 30 hr after
transfection by counting the ratio of fluorescent cells (EGFP-positive)
versus total number of cells (*p , 0.01 vs EGFP vector). Data represent
the mean of three independent experiments.
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downstream protease, caspase-3 (Zou et al., 1999). The protec-
tion from apoptosis induced by caspase-9 transfection (Fig. 7)
combined with the reduced activity of its downstream effector,
caspase-3, in wtHtt cells (Fig. 6A) and to the evidence that the
same cells could be killed by transfection of a constitutively
active form of caspase-3 (Fig. 6 B) leads us to suggest that
wtHtt acts upstream of caspase-3 and likely at the level of
caspase-9 activation.
A poly (Q) expansion in the Htt gene is suggested to produce
a toxic gain-of-function effect. Accordingly, expression of muHtt
induces cell death in transgenic animals and in cell culture sys-
tems (Cooper et al., 1998; Hackam et al., 1998; Lunkes and
Mandel, 1998; Reddy et al., 1998; Hodgson et al., 1999). Striatal-
derived ST14A cells overexpressing muHtt undergo a similar fate
when challenged with various stress stimuli (serum withdrawal,
3-NP exposure). In our system we found that, in the presence of
muHtt, DNA fragmentation is accompanied by an increased
caspase-3-like activation, which is consistently above the level
found in parental ST14A cells. These data suggest that the toxic
effect of muHtt converges onto caspase-3. As a further demon-
stration, we transfected the zymogen form of caspase-3, which
normally does not lead to apoptosis (Srinivasula et al., 1998), into
muHtt expressing cells and found an increase in the number of
TUNEL-positive cells. Increased activation of caspase-3 and
caspase-9 was also recently reported in lymphoblasts from Hun-
tington’s disease patients exposed to chemical inducers of apo-
ptosis (Sawa et al., 1999). Interestingly, comparisons of the phe-
notypes of cells expressing different muHtt constructs reveal that
the toxicity of the polyglutamine repeat is modulated by the
protein backbone. Indeed we found that FLmu protein promotes
cell death only by selective stimuli (BAD or caspase-3 transfec-
tions), whereas N548mu truncation promotes death by a larger
range of death stimuli (BAD or caspase-3 transfections, 3-NP
exposure, serum withdrawal). These results highlight the pos-
sibility that truncated versions of poly(Q) proteins induce a
wider spectrum of cytotoxic events than the full-length pro-
Figure 7. TUNEL of the stable cell lines expressing Htt after transfection with different death inducers. ST14A (dotted bars), N548wt (7–12 clone, black
bars), N548mu (8–11 clone, horizontal striped bars), and FLmu (10–11 clone, diagonal striped bars) cells were transfected with 1 mg of the indicated
plasmids (0.4 mg for BIK and BAK) or a control protein. The inset depicts a typical TUNEL readout. A and B show gating on the EGFP-expressing cell
population. C shows TUNEL staining of cells transfected with the control protein; D shows TUNEL staining of cells transfected with p55/TNFR. The
control protein used is 14-3-3. In ST14A cells p55, BIK, BAK, and caspase-9 induce apoptosis, whereas BAD and caspase-3 show no effect. Apoptosis
by all inducers is blocked in cells expressing wtHtt. FLmu cells show similar levels of apoptosis as the parental line for p55, BIK, BAK, and caspase-9
and a marked increase in BAD and caspase-3-induced apoptosis. This increase is also seen in N548mu cells. Shown is the average of three independent
experiments. Error bars show the average deviation.
Rigamonti et al. • Wild-Type Huntingtin Is a Pro-Survival Protein J. Neurosci., May 15, 2000, 20(10):3705–3713 3711
teins and support the notion that proteolytic cleavage is im-
portant in HD.
Further analysis of the roles and mechanisms of action of wtHtt
will help to better understand its physiological functions and
whether and how the poly(Q) expansion in the mutated protein
interferes with those and/or other activities.
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